| PACKAGING TYPE: | 9x10 Blister (9 Strips In 1 Box) |
| COMPOSITION: | Each Film Coated Tablet Contains: Empagliflozin 25 Mg, Linagliptin 5 Mg, Excipients Q.s. Colour: Approved colour used. |
| FORMULATION: | Tablet |
| Description: | EMPACON L 25/5 Tablet is a fixed-dose combination of Empagliflozin 25 mg and Linagliptin 5 mg used to manage type 2 diabetes mellitus in adults. Empagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor that helps eliminate excess glucose through urine, while Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that improves glycemic control by enhancing insulin secretion and decreasing glucagon levels. Together, they offer a complementary mechanism to effectively lower blood glucose levels and improve overall glycemic control. |
| Side Effects: | Urinary tract infections Increased urination Nasopharyngitis (cold symptoms) Headache Hypoglycemia (especially if used with insulin or sulfonylureas) Genital infections |
| Precaution: | For oral use only. Not recommended for children unless prescribed. Consult your doctor if pregnant, nursing, or taking other medications. |
| Product Benefits: | Glyxambi 25/5 Tablet by Boehringer Ingelheim |













